Drug Trial Radar · NCT00659100
A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment
Last checked: Nov 19, 2026Latest source record: Feb 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,254
Actual
Start
Aug 2006
Primary completion
Not stated
Study completion Jan 2007
Sponsor
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Pfizer (PFE)
- Sponsor type
- Industry
- First posted
- Apr 16, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess consumers' behaviors related to gabapentin self- selection and use, relative to warnings and directions for use, as described in the proposed over-the-counter (OTC) product label.
Conditions
- Transient Insomnia
Interventions
GabapentinDrug
Gabapentin 50 mg oral capsule 30 minutes before bedtime
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects who selected or purchased gabapentin for use (patients had symptoms consistent with indication and no contraindications)Time frame: Throughout Day 90
- Subject compliance with directions for use (number of capsules per dose and the number of doses per day)Time frame: Throughout Day 90
Locations
35 sites in 1 country. Site status is shown where the registry gives one.
Pfizer Investigational Site
Anaheim, California
Pfizer Investigational Site
Bonita, California
Pfizer Investigational Site
Fallbrook, California
Pfizer Investigational Site
Hacienda Heights, California
Pfizer Investigational Site
La Mesa, California
Pfizer Investigational Site
Oceanside, California
Pfizer Investigational Site
Orange, California
Pfizer Investigational Site
San Dimas, California
Pfizer Investigational Site
Pembroke Pines, Florida
Pfizer Investigational Site
Weston, Florida
Pfizer Investigational Site
Baltimore, Maryland
Pfizer Investigational Site
Elk River, Minnesota
Pfizer Investigational Site
Northfield, Minnesota
Pfizer Investigational Site
Red Wing, Minnesota
Pfizer Investigational Site
Saint Louis Park, Minnesota
Pfizer Investigational Site
Holly Springs, Mississippi
Pfizer Investigational Site
Belton, Missouri
Pfizer Investigational Site
Independence, Missouri
Pfizer Investigational Site
Albuquerque, New Mexico
Pfizer Investigational Site
Albuquerque, New Mexico
Pfizer Investigational Site
Taos, New Mexico
Pfizer Investigational Site
Cary, North Carolina
Pfizer Investigational Site
Chapel Hill, North Carolina
Pfizer Investigational Site
Raleigh, North Carolina
Pfizer Investigational Site
Raleigh, North Carolina
Pfizer Investigational Site
Raleigh, North Carolina
Pfizer Investigational Site
Houston, Texas
Pfizer Investigational Site
Pearland, Texas
Pfizer Investigational Site
Bountiful, Utah
Pfizer Investigational Site
Ogden, Utah
Pfizer Investigational Site
Salt Lake City, Utah
Pfizer Investigational Site
Syracuse, Utah
Pfizer Investigational Site
West Valley City, Utah
Pfizer Investigational Site
Falls Church, Virginia
Pfizer Investigational Site
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.